We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
FERINJECT (Vifor Pharma Pty Ltd)
Product name
FERINJECT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
189 (255 working days)
Active ingredients
ferric carboxymaltose
Registration type
EOI
Indication
FERINJECT is indicated for the treatment of iron deficiency in adults and adolescents aged 14 years and older when:
- oral iron preparations are ineffective
- oral iron preparations cannot be used
- there is a clinical need to deliver iron rapidly
The diagnosis of iron deficiency must be based on laboratory tests.
FERINJECT is indicated for the treatment of iron deficiency anaemia in children aged 1 to 13 years when:
- oral iron preparations are ineffective
- oral iron preparations cannot be used
The diagnosis of iron deficiency anaemia must be based on laboratory tests.